Aminolevulinic acid
| Clinical data | |
|---|---|
| Trade names | Levulan, NatuALA, Ameluz, others |
| Other names | 5-aminolevulinic acid |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a607062 |
| License data | |
| Routes of administration | Topical, By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.003.105 |
| Chemical and physical data | |
| Formula | C5H9NO3 |
| Molar mass | 131.131 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 118 °C (244 °F) |
| |
| |
| (verify) | |
δ-Aminolevulinic acid (also dALA, δ-ALA, 5ALA, 5-ALA or 5-aminolevulinic acid), an endogenous non-proteinogenic amino acid, is the first compound in the porphyrin synthesis pathway, the pathway that leads to heme in mammals, as well as chlorophyll in plants.
5-ALA is used in photodynamic detection and surgery of cancer.